Skylar-Scott, Irina A.
Sha, Sharon J.
Article History
Accepted: 30 July 2023
First Online: 12 August 2023
Declarations
:
: I.S.S. has received funding for clinical trials research from Eli Lilly, Eisai, Biogen, Janssen, Novartis, Alector, AbbVie, Genentech/Roche, Cortexyme, UCB Biopharma, and Alzheon.S.J.S. has received consulting fees/honoraria from Biogen, Guidepoint Global, ExpertConnect, UpToDate, ReachMD, and Forefront Collaborative; and funding for research from Biogen, Janssen, Genentech, Novartis, Eisai, and Eli Lilly.
: This article does not contain any studies with human or animal subjects performed by any of the authors.